Unicough Syrup (Levodropropizine)

Adult dose

Adults: Administer 60 mg of levodropropizine orally per dose, 3 times daily at intervals of at least 6 hours. Adjust the dose appropriately according to age and symptoms.

Child dose

10～20 kg: Administer 18 mg of levodropropizine orally per dose, 3 times daily at intervals of at least 6 hours. 20～30 kg: Administer 30 mg of levodropropizine orally per dose, 3 times daily at intervals of at least 6 hours.

This medication should not be used in certain patients. Individuals who have allergies to this drug or its components should not take it. Patients with excessively increased bronchial mucus secretion should not use this medication. Patients with a special condition called dyskinesia of cilia, such as Kartagener syndrome or ciliary dyskinesia, should not take this medication. Women who are pregnant or likely to become pregnant, as well as nursing mothers, should also avoid this medication. Patients with severely impaired liver function should not use this medication. Patients with severe heart failure or significantly decreased kidney function should use this medication with caution. Elderly individuals and children under 2 years of age should also take this medication with care. After taking it, gastrointestinal symptoms such as nausea, dyspepsia, diarrhea, and vomiting may occur. Symptoms related to the central nervous system may include fatigue, lethargy, coma, headache, and dizziness. Tachycardia may also occur. Very rarely, allergic reactions on the skin may occur. Rarely, serious immune response known as anaphylaxis has also been reported. Caution should be exercised when performing tasks that require alertness such as driving or operating machinery after taking this medication, as drowsiness or semi-consciousness may occur. Especially when taken with alcohol, these symptoms may worsen. Extra care should be taken when used with sedatives. Pregnant or nursing women should avoid this medication. This medication should be kept in a safe place out of reach of children. Additionally, transferring the medication to another container should be avoided as it poses a risk of accidents and can be harmful to the maintenance of the medication's quality.

• nausea
• carbonation
• dyspepsia
• diarrhea
• vomiting
• fatigue
• functional impairment
• half-life
• coma
• headache

This medication should be stored in a tightly closed container to prevent exposure to air or moisture, and it is important to store it at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness over time.

Appearance

A colorless to pale yellow syrup with a sweet taste and strawberry fragrance contained in a white opaque bottle.

Package unit

500 milliliters/bottle